- EBS -0.46%
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
Yahoo Finance · 2 weeks ago
Open | 4.4100 |
High | 4.5350 |
Low | 4.2100 |
Mkt Cap | 227.95M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.3700 |
52 Wk. Low | 1.4200 |
52 Wk. High | 9.9600 |
Related stocks
Multinational biopharmaceutical company headquartered in Gaithersburg, Maryland, USA
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 300.4M | 82.80% ▲ |
Net Income | 9M | - |
Diluted EPS | 0.59 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.94 | - |
Q1 2024 | -$0.86 | $0.59 |
Q4 2023 | -$0.19 | -$0.77 |
S&P FuturesES=F | 5,251.50+5.25 (+0.10%) |
Dow FuturesYM=F | 39,649.00+7.00 (+0.02%) |
Nasdaq FuturesNQ=F | 18,293.00+38.00 (+0.21%) |
80.950+3.85% | |
Novavax, Inc.NVAX | 8.88+98.66% |
Bitcoin USDBTC-USD | 61,577.09+1.01% |